Milestone Pharmaceuticals Posts $2.96 Million in Q3 Revenue, Beating Estimate

John Kim

1 min read

Add as a preferred source on Google

Milestone Pharmaceuticals Posts $2.96 Million in Q3 Revenue, Beating Estimate

Its GAAP loss per share was $0.18, 4 cents smaller than estimated.

By John Kim

Published Nov 13, 2026, 7:25 AM EST

A white capsule rests beside a tilted brass balance / TokenPost.ai

Milestone Pharmaceuticals posted $2.96 million in third-quarter revenue, exceeding the estimate by $1.96 million, while its per-share loss was smaller than estimated.

GAAP earnings per share showed a loss of $0.18, 4 cents smaller than estimated.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.